ATE552272T1 - Myostatin-isoform - Google Patents
Myostatin-isoformInfo
- Publication number
- ATE552272T1 ATE552272T1 AT05790714T AT05790714T ATE552272T1 AT E552272 T1 ATE552272 T1 AT E552272T1 AT 05790714 T AT05790714 T AT 05790714T AT 05790714 T AT05790714 T AT 05790714T AT E552272 T1 ATE552272 T1 AT E552272T1
- Authority
- AT
- Austria
- Prior art keywords
- present
- sequences
- myostatin
- muscle
- splice variants
- Prior art date
Links
- 102000004472 Myostatin Human genes 0.000 title abstract 2
- 108010056852 Myostatin Proteins 0.000 title abstract 2
- 102000001708 Protein Isoforms Human genes 0.000 title 1
- 108010029485 Protein Isoforms Proteins 0.000 title 1
- 210000003205 muscle Anatomy 0.000 abstract 3
- 241001465754 Metazoa Species 0.000 abstract 2
- 230000037257 muscle growth Effects 0.000 abstract 2
- 108091035707 Consensus sequence Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 238000009394 selective breeding Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Biotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ53569604A NZ535696A (en) | 2004-09-30 | 2004-09-30 | Myostatin splice variants ( MSV ) |
| NZ53839605 | 2005-02-22 | ||
| PCT/NZ2005/000250 WO2006036074A1 (en) | 2004-09-30 | 2005-09-30 | Myostatin isoform |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE552272T1 true ATE552272T1 (de) | 2012-04-15 |
Family
ID=36119161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05790714T ATE552272T1 (de) | 2004-09-30 | 2005-09-30 | Myostatin-isoform |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20080118487A1 (https=) |
| EP (1) | EP1799709B1 (https=) |
| JP (1) | JP5335239B2 (https=) |
| AT (1) | ATE552272T1 (https=) |
| CA (1) | CA2582940A1 (https=) |
| WO (1) | WO2006036074A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100898149B1 (ko) | 2007-04-05 | 2009-05-19 | 주식회사 에스엔피 제네틱스 | 소의 근내지방도와 연관되어 있는 티틴-캡 다형성 |
| HRP20251426T1 (hr) | 2013-05-06 | 2026-01-02 | Scholar Rock, Inc. | Sastavi i postupci za modulaciju faktora rasta |
| WO2019195679A1 (en) * | 2018-04-06 | 2019-10-10 | Intrexon Corporation | Tilapia with enhanced growth characteristics |
| CN113474013B (zh) | 2019-03-01 | 2024-06-21 | 神户天然物化学株式会社 | 肌肉生长抑制素剪接变体衍生蛋白对肌肉生长抑制素信号的抑制及其利用 |
| US20240229036A9 (en) * | 2021-02-26 | 2024-07-11 | Knc Laboratories Co., Ltd. | Nucleic acid medicine expressing splicing variant of myostatin |
| CN115201474A (zh) * | 2022-08-12 | 2022-10-18 | 万华普曼生物工程有限公司 | 一种新型冠状病毒抗体的快速检测试剂盒及其制备方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| US4487325A (en) | 1982-07-06 | 1984-12-11 | Owens-Illinois, Inc. | Crown closures and containers |
| US7393682B1 (en) * | 1993-03-19 | 2008-07-01 | The Johns Hopkins University School Of Medicine | Polynucleotides encoding promyostatin polypeptides |
| US5874409A (en) * | 1995-06-07 | 1999-02-23 | La Jolla Pharmaceutical Company | APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies |
| WO1998033887A1 (en) | 1997-02-05 | 1998-08-06 | The Johns Hopkins University School Of Medicine | Growth differentiation factor-8 |
| US6656475B1 (en) * | 1997-08-01 | 2003-12-02 | The Johns Hopkins University School Of Medicine | Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| US6369201B1 (en) * | 1998-02-19 | 2002-04-09 | Metamorphix International, Inc. | Myostatin multimers |
| US7056512B1 (en) | 1999-07-20 | 2006-06-06 | Pharmexa A/S | Method for down-regulating GDF-8 activity |
| US7368534B2 (en) * | 2000-01-18 | 2008-05-06 | Orico Limited | Myostatin and mimetics thereof |
| CA2484941A1 (en) | 2002-07-24 | 2004-02-05 | Intercell Ag | Antigens encoded by alternative reading frame from pathogenic viruses |
| EP2192129A1 (en) * | 2002-09-16 | 2010-06-02 | Johns Hopkins University | Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
| NZ529860A (en) * | 2003-11-28 | 2006-10-27 | Ovita Ltd | Muscle growth regulator mighty and use in promoting muscle mass and treating muscle wasting diseases |
| CA2551877A1 (en) * | 2003-12-31 | 2005-07-21 | Schering-Plough Ltd. | Neutralizing epitope-based growth enhancing vaccine |
| NZ538097A (en) | 2005-02-07 | 2006-07-28 | Ovita Ltd | Method and compositions for improving wound healing |
| US20070190056A1 (en) | 2006-02-07 | 2007-08-16 | Ravi Kambadur | Muscle regeneration compositions and uses therefor |
| US8309068B2 (en) * | 2006-08-03 | 2012-11-13 | Myostin Therapeutics Pty Ltd. | Isolated polypeptides and methods of improving muscle strength |
-
2005
- 2005-09-30 US US11/576,449 patent/US20080118487A1/en not_active Abandoned
- 2005-09-30 AT AT05790714T patent/ATE552272T1/de active
- 2005-09-30 WO PCT/NZ2005/000250 patent/WO2006036074A1/en not_active Ceased
- 2005-09-30 JP JP2007534532A patent/JP5335239B2/ja not_active Expired - Fee Related
- 2005-09-30 CA CA002582940A patent/CA2582940A1/en not_active Abandoned
- 2005-09-30 EP EP05790714A patent/EP1799709B1/en not_active Expired - Lifetime
-
2011
- 2011-04-12 US US13/085,263 patent/US8455448B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006036074A1 (en) | 2006-04-06 |
| JP2008514227A (ja) | 2008-05-08 |
| US20110258712A1 (en) | 2011-10-20 |
| CA2582940A1 (en) | 2006-04-06 |
| EP1799709B1 (en) | 2012-04-04 |
| EP1799709A1 (en) | 2007-06-27 |
| US20080118487A1 (en) | 2008-05-22 |
| EP1799709A4 (en) | 2008-11-12 |
| US8455448B2 (en) | 2013-06-04 |
| JP5335239B2 (ja) | 2013-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124332T1 (el) | Πεγκυλιωμενες ενωσεις ανασυνδυασμενης ανθρωπινης αυξητικης ορμονης | |
| AR061930A1 (es) | Mimeticuerpos de glp-1 humanos, composiciones, metodos y usos | |
| SG151315A1 (en) | Human glp-1 mimetibodies, compositions, methods and uses | |
| NO20111324A1 (no) | Rekombinant MVA-virus | |
| ATE548388T1 (de) | An den interleukin-4-rezeptor bindende antikörper | |
| ATE395871T1 (de) | Marknagel zur behandlung von proximalen oberschenkelknochenbrüchen | |
| EA200900177A1 (ru) | Замещенные ациланилиды и способы их применения | |
| EA201000865A1 (ru) | Комбинация ингибиторов протеинтирозинфосфатазы и гормона роста человека, предназначенная для лечения атрофии мышц и родственных нарушений | |
| IS7770A (is) | Hlutleysandi mótefni gegn GDF-8 og notkun theirra | |
| ATE495739T1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
| EA200900345A1 (ru) | Замещенные ациланилиды и способы их применения | |
| EA200601107A1 (ru) | Композиции, получаемые из морских растений, для обеспечения питания для старческой и поврежденной окружающей средой кожи | |
| ATE499105T1 (de) | Behandlung oder vorbeugung von haut- oder gewebezuständen bei tieren unter verwendung von boryloxypyridylmethanonen | |
| LU93259I2 (fr) | LETIFEND (Protein Q) | |
| EP1018976A4 (en) | Head-only animal exposure chambers | |
| DE59510466D1 (de) | Lebendvakzine zur behandlung von tumorerkrankungen | |
| ATE225803T1 (de) | Peptid zur verringerung des triglyzeridspiegels des blutes und inhibitor für den anstieg des triglyzeridspiegels des blutes, der das peptid als aktiven bestandteil enthält | |
| ATE552272T1 (de) | Myostatin-isoform | |
| DK1599215T3 (da) | Anvendelse af tryptophanrige peptider fra mælkeproteinhydrolysat til behandling af overvægt og fedme | |
| ATE285794T1 (de) | Die verwendung von retinoid antagonisten oder agonisten für die behandlung von gelenk-und knochenpathologien | |
| NO995692D0 (no) | Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse | |
| DE60324784D1 (de) | Behandlung zur reduzierung der zunahme des körpergewichts | |
| NO20075272L (no) | Humane GLP-1 "mimetibodies", sammensetninger, fremgangsmater og anvendelser | |
| DE60113380D1 (de) | Methoden zur identifizierung von zusammensetzungen, die für die behandlung von fettleibigkeit nützlich sind, unter verwendung von foxc2 | |
| KR20080006419U (ko) | 원적외선과 기가 방사되는 옥 조끼 |